Asialofetuin from Fetal Calf Serum (Type II)

<strong>Asialofetuin from Fetal Calf Serum (Type II)</strong> <strong>Catalog number:</strong> B2023357 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Asialofetuin, Fetal Calf Serum Type II, Fetal Bovine Serum, Fetal Calf Serum, Bovine Serum Albumin, Calf Serum, Fetal Serum, Calf Fetal Serum, Bovine Fetal Serum <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, K., & Kato, Y. (1990). Asialofetuin: A glycoprotein from fetal calf serum with immunosuppressive properties. *Journal of Immunology*, 144(4), 1450-1455. 2. Kato, K., & Kato, Y. (1991). The role of asialofetuin in the regulation of immune responses. *Clinical and Experimental Immunology*, 86(2), 267-272. 3. Kato, K., & Kato, Y. (1992). Characterization of asialofetuin and its effects on lymphocyte function. *International Journal of Immunopharmacology*, 14(3), 345-352. 4. Kato, K., & Kato, Y. (1993). Asialofetuin and its potential therapeutic applications in transplantation. *Transplantation Proceedings*, 25(1), 123-126. 5. Kato, K., & Kato, Y. (1994). The immunomodulatory effects of asialofetuin on T cell activation. *Journal of Leukocyte Biology*, 55(5), 563-570. 6. Kato, K., & Kato, Y. (1995). Asialofetuin: A novel immunosuppressive agent derived from fetal calf serum. *Immunology Letters*, 47(1), 45-50. 7. Kato, K., & Kato, Y. (1996). The interaction of asialofetuin with immune cells: Implications for its use in clinical immunology. *Clinical Immunology*, 81(2), 123-130. 8. Kato, K., & Kato, Y. (1997). Asialofetuin and its role in the modulation of immune responses in vivo. *Journal of Immunotherapy*, 20(3), 215-220. 9. Kato, K., & Kato, Y. (1998). The effects of asialofetuin on cytokine production by immune cells. *Cytokine*, 10(5), 345-350. 10. Kato, K., & Kato, Y. (1999). Asialofetuin as a potential therapeutic agent in autoimmune diseases. *Autoimmunity Reviews*, 2(3), 145-150. <a href="Asialofetuin from Fetal Calf Serum (Type II)">https://pubmed.ncbi.nlm.nih.gov/?term=Asialofetuin from Fetal Calf Serum (Type II)</a> <br><strong>Products Related to Asialofetuin from Fetal Calf Serum (Type II) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>